Despite a sharp worldwide decline in the incidence and mortality due to gastric cancer during the second half of the 20th century, gastric cancer remains the world's second leading cause of cancer-related deaths. Variants of gastric cancer account for approximately 5% of all stomach carcinomas. Herein, we report on a rare case of combined germ cell tumor and adenocarcinoma that arose in the stomach of a 68-year-old woman with a high level of alpha-fetoprotein in the serum. Clinical and pathological findings are presented.
G erm cells tumors most frequently occur in the gonads. Extragonadal localization is rare and concerns mainly midline locations such as the mediastinum, retroperitoneum, and pineal gland. Yolk sac tumor (YST) is a malignant tumor originating from the germ cell. Gastric adenocarcinoma with a yolk sac component is extremely rare with only a few cases reported in the literature [1] . Herein, we present a rare case of gastric cancer with adenocarcinoma and YST components in a 68-year-old woman who presented with metastatic para-aortic lymphadenopathy (LAP).
CASE REPORT
A 68-year-old woman presented with symptoms of appetite loss, weight loss, and abdominal pain that had persisted for 4 months. During a general health examination at a local clinic, para-aortic LAP was detected by abdominal tomography. Tru-Cut biopsy revealed adenocarcinoma with probable primary ovarian or other serosal origin. She was referred to our hospital for further evaluation and management. There was no significant physical findings. Except for anemia (level of hemoglobin: 11.1 g/dl), hematological and biochemical parameters were normal. The level of alpha-fetoprotein (AFP) in her serum was elevated to 50 ng/mL (normal: 0-32 ng/mL), whereas levels of carcinoembryonic antigen (CEA) (normal: 0-3 ng/mL), and human chorionic gonadotropin (HCG) (normal: 0-10 mlU/ml) in the serum were within the normal limits. Computed tomography of the abdomen showed gastric wall thickness at the lesser curvature of the mid body in addition to para-aortic lymph node enlargement.
Upper digestive tract endoscopy showed a 5-6 cmulcerofungating mass in the lesser curvature of the gastric body. Histopathologic findings following gastroduodenoscopy revealed an invasive poorly differantiated adenocarcinoma. Total gastrectomy with D2 lymph node dissection and esophagojejunostomy were performed. Precise histopathological examination of resected specimens revealed the presence of a moderate-to-poorly differentiated invasive adenocarcinoma, with features of YST. An elevated tumor, 6×5×3 cm in size, with surface ulceration and hemorrhage was located in the antral minor curvature of the stomach. The tumor was primarily located in the mucosa and submucosa. The final diagnosis was T3, N3, M0, and stage III according to the Japanese classification of gastric cancer. Metastases to perigastric lymph nodes were also observed. The gastric tumor was composed of two histological types: YST and a moderately differentiated tubular adenocarcinoma. Majority of the tumor was occupied by a YST which showed the most common reticular pattern (Fig. 1A, B) . Schiller-Duval bodies were also sporadically observed. Other com-
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ponents of germ cell tumors, like embryonal carcinomas and choriocarcinomas, were not identified. In the yolk sac component, tumor cells showed immunoreactivity for cytokeratin (Fig. 1C) and AFP ( Fig. 1D) but not for CEA, chromogranin A, cytokeratins 7 and 20, β-HCG , CDX2, placental alkaline phosphatase, and CD30. Focal staining for AFP was also observed in the adenocarcinoma foci (Fig. 2) . Alternatively, CEA was strongly positive in the adenocarcinoma. The postoperative period was uneventful, and the patient was discharged on the 9 th postoperative day with a plan for chemotherapy. The patient died in 8 months after the surgery.
DISCUSSION
Gastric cancer remains one of the deadly diseases with poor prognosis. Sixteen cases of gastric YST have been reported in the medical literature since the description of the tumor in 1985 by Gharcia et al. (Table 1 ). It is notable that 11 cases (68.75%) have been reported to have adenocarcinoma components as well. The level of AFP in the serum was increased in most of these cases [2] . Six of the 16 patients with gastric YST had rapidly fatal clinical courses, consistent with the highly aggressive nature of these neoplasms at other sites. According to reported literature, gastric YST usually affect middleaged and elderly people with male preponderance, as confirmed by our case. They are aggressive neoplasms with early metastases. Five of the reported patients had long-term survival and one was a autopsy case. The remaining four patients had short survival times. The clinical presentation in most pa- 
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tients is remarkably uniform. YSTs of the stomach that have been reported to be large masses within the stomach. Although there has been at least one report of YST that did not respond at all to germ cell regimens, YSTs of the stomach should be treated with germ cell regimens, such as bleomycin, etoposide, and cisplatin or vinblastine, ifosfamide, and cisplatine. However, the adenocarcinomatous components may not be as responsive as the germ cell tumors. The disease tends to rapidly recur in spite of initial response to chemotherapy. Controversy remains regarding the origin of extragonadal germ cell tumors. These tumors can be found anywhere on the midline, particularly the retroperitoneum, anterior mediastinum, sacrococcyx, and pineal gland. Other less common sites include the orbit, suprasellar area, palate, thyroid, submandibular region, anterior abdominal wall, stomach, liver, vagina, gallbladder, pancreas, and prostate [3] . The classic theory suggests that germ cell tumors in these areas are derived from migrating germ cells sequestered in the midline during embryogenesis [4] . This may be the case of pure YSTs occurring in the stomach [5] [6] [7] [8] . An alternative theory suggests that the tumor originates due to aberrant differentiation of somatic cells [9, 10] . This might explain cases of YST occurring in the stomach or lung. Aberrant differentiation of adenocarcinomas may explain the devel- 
CONCLUSION
In patients with gastric carcinoma with a high level of AFP in the serum, YST is the likely diagnosis.
Although the reported number of gastric adenocarcinomas with a yolk sac component is not so large to predict a proper outcome, the presence of the yolk sac component may be an indication of poor prognosis in terms of duration of survival.
